Do I need to register each single-patient investigational new drug application (IND) or protocol exception (including for emergency use) separately?

No, manufacturers or Sponsors accepting requests for single-patient investigational new drug applications (INDs) or protocol exceptions (including for emergency use) should provide only one expanded access record.